An evaluation of the effect of tasocitinib (CP-690,550), an oral Janus kinase inhibitor, on pruritus in patients with plaque psoriasis

Authors
Category Primary study
JournalJournal of the American Academy of Dermatology
Year 2011
This article has no abstract
Epistemonikos ID: a8239d92094bb2e2d3120bdef99966e0b3f1392a
First added on: Feb 04, 2025